Sponsor:
Avalyn Pharma Inc.
Code:
NCT06329401
Conditions
Pulmonary Fibrosis
Progressive Pulmonary Fibrosis
Pulmonary Fibrosis Secondary to Systemic Sclerosis
Pulmonary Fibrosis, Interstitial Lung Disease
Interstitial Lung Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
AP01
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-04-08. This information was provided to ClinicalTrials.gov by Avalyn Pharma Inc. on 2026-04-06.